David R Elizondo insider trades: Ats Medical (ATSI) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 30, 2010 | ATSI | ↓ Sell | 13,125 | $3.96 | $52K | Direct | Jul 1, 2010 (1d) |
| Mar 16, 2010 | ATSI | ↓ Sell | 14,760 | $2.51 | $37K | Direct | Mar 17, 2010 (1d) |
| Sep 30, 2009 | ATSI | ↓ Sell | 3,770 | $2.72 | $10K | Direct | Sep 30, 2009 (0d) |
| Jul 31, 2009 | ATSI | ↓ Sell | 3,750 | $3.47 | $13K | Direct | Aug 3, 2009 (3d) |
| Mar 16, 2009 | ATSI | ↓ Sell | 9,754 | $2.16 | $21K | Direct | Mar 17, 2009 (1d) |
| Sep 30, 2008 | ATSI | ↓ Sell | 3,450 | $2.80 | $10K | Direct | Sep 30, 2008 (0d) |
| Mar 14, 2008 | ATSI | ↓ Sell | 3,493 | $1.45 | $5K | Direct | Mar 17, 2008 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About David R Elizondo's insider trades
David R Elizondo is VP-Research & Development at Ats Medical (ATSI). Since Mar 14, 2008, David has reported no open-market purchases and 7 sales worth $148K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (8 filings), grants and awards (6 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ATSI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.